Skip to main content

Advertisement

Log in

Reimbursement and Investment: Prospective Payment and For-Profit Hospitals’ Market Share

  • Published:
Journal of Industry, Competition and Trade Aims and scope Submit manuscript

Abstract

This paper studies how the change from retrospective cost-based reimbursement to a prospective payment system shifted hospital investment strategies from quality-enhancing technologies to cost-saving technologies. A consequence of this change was the opportunity for for-profit hospitals to capture a larger share of the market. When all of a patient’s treatment costs are paid under a retrospective average cost-based program, not-for-profit hospitals invest only in the quality-enhancing technology. For-profit hospitals have no incentive to invest in either technology. As a result, most patients select not-for-profit hospitals and for-profit hospitals attract only those few patients who have extreme time preference. When hospitals are reimbursed prospectively, however, not-for-profit hospitals invest in both quality-improving and the cost-saving technologies, as do for-profit hospitals, although at lesser amounts. Quality and market shares are more equal under prospective payment, helping to explain the increasing market share of for-profit hospitals as prospective payment has become the norm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Notes

  1. In the analysis we consider the simplest case where prices are exogenous and paid fully by the government. Hence for simplicity and expediency we do not include price as an argument in the demand facing individual providers. A version of the model with endogenous prices is available from the authors. Our waiting time preference plays the same role as travel time in Brekke et al. (2011) and Herr (2011) and in fact could be construed in exactly the same way—patients will travel for quality only if it is sufficiently different to justify additional travel costs. This would make T exogenous and simplify the model but not change the results.

  2. This is essentially Cournot style competition.

  3. The last property of the unit cost treatment cost function says that the cost saving technology cannot fully offset the cost increasing from the quality enhancing technology.

  4. Investing in t 2k pushes \( \overline c \) lower, but never to negative amounts.

  5. This Newhouse (1970) type utility function is formalized by Sloan (2000). In his model, U = U(X,Y,π) where X = output, Y = quality, and π = profit. In our model, we extract profit from the utility of the not-for-profit hospital, and set it as a non-negative constraint. Hoerger (1991) finds empirical support that the not-for-profit hospital maximizes utility subject to zero profit constraint and Horwitz and Nichols (2009) conclude that the empirical evidence fits best with hospitals that maximize their own output.

  6. One of the differential characteristics of not-for-profit enterprises is its ability to attract charitable donations. Even if there were tax advantages for donating to for-profit enterprise, few donors would do so because they would simply be enriching the for-profit firm’s shareholders (Hansmann 1980, 1998 and Sloan 2000). Although the potential for donations would seem to be a big advantage for not-for-profit hospitals, in recent years, donations have become a relatively unimportant source of revenue for not-for-profit hospitals. In 1983, only 0.4 % of revenue is derived from the donations. One of the reasons for the decline is thought as the growth of health care insurance (Sloan 2000).

  7. The money constraint of the not-for-profit hospital can be decomposed as the profit part (Q n (q f  − q n )[p n  − c(t 1n , t 2n )] − r 1 t 1n  − r 2 t 2n ) and the donation part (D[Q n (q f  − q n ), q n (t 1n )]). Because the not-for-profit hospital can raise money by fundraising, it can actually have negative operating revenue as long as the total net revenue is non-negative.

  8. One may motivate this behavior by a minute unreimbursed fixed transactions cost that is incurred whenever a hospital undertakes any investment. When there is no possible return from an investment, the hospital will choose to not do it.

  9. Siciliani (2006) argues that hospitals can influence its tariff under prospective payment through treatment choice, thus assuming a fully prospective payment is simplistic, We follow the common assumption of a single lump-sum payment for each patient used by Allen and Gertler (1991), Ma (1994) and over a dozen additional papers cited by Siciliani. Since all our patients are the same, this is an appropriate model for our purposes. Our primary results would hold under different payment amounts to the hospitals, as long as the payment amounts are not endogenous.

  10. This extension is available from the authors.

  11. Coverage is not mutually exclusive. These percentages indicate that approximately 10 % of the population has both private health insurance and coverage from a government program.

References

  • Allen R, Gertler P (1991) Regulation and the provision of quality to heterogeneous consumers: the case of prospective pricing of medical services. J Regul Econ 3:361–375

    Article  Google Scholar 

  • Brekke K, Siciliani L, Straume O (2011) Hospital competition and quality with regulated prices. Scand J Econ 113:444–469

    Article  Google Scholar 

  • Bureau of the Census (2009) Income, poverty, and health insurance coverage in the United States: 2008. http://www.census.gov/prod/2009pubs/p60-236.pdf.

  • Burtler P, Bone R, Field T (1985) Technology under Medicare Diagnosis-Related Groups prospective payment: implications for medical intensive care. Chest 87:229–234

    Article  Google Scholar 

  • Chalkley M, Malcomson J (2000) Government purchasing of health services In: Culyer A, Newhouse J (eds) Elsevier, pp 847–890

  • Ellis R, McGuire T (1993) Supply-side and demand-side cost sharing in health care. J Econ Perspect 7:135–151

    Google Scholar 

  • FrankR, Salkever D (2000) Market forces, diversification of activity, and the mission of not-for-profit hospitals. In: Cutler D (ed) The changing hospital industry: Comparing for-profit and not-for-profit insitutions. University of Chicago Press. Available on-line at http://www.nber.org/books/cutl00-1.

  • Friesner D, Rosenman R (2002) A dynamic property rights theory of the firm. Int J Econ Bus 9:311–333

    Article  Google Scholar 

  • Gaynor M, Town R (2012) Competition in health care markets. In: Pauly M, McGuire T, Barros B (eds) Handbook of health economics Vol. 2. Elsevier pp 499–627

  • Gottlober P (2001) Medicare hospital prospective payment system: How DRG rates are calculated and updated. Office of the Inspector General, US Department of Health and Human Services. http://oig.hhs.gov/oei/reports/oei-09-00-00200.pdf. Last accessed May 22, 2012

  • Hansmann H (1980) The role of nonprofit enterprise. Yale Law J 89:835–901

    Article  Google Scholar 

  • Hansmann H (1998) Ownership of the firm. J Law Econ Org 4:267–304

    Google Scholar 

  • Henderson J (2009) Health economics and policy. 4th edn, South-Western Cengage Learning 270

  • Herr A (2011) Quality and welfare in a mixed duopoly with regulated prices: the case of a public and private hospital. Ger Econ Rev 12:422–437

    Article  Google Scholar 

  • Hillman A, Schwartz S (1985) The adoption and diffusion of CT and MRI in the United States: a comparative analysis. Med Care 23:1283–1294

    Article  Google Scholar 

  • Hirth R, Chernew M, Orzol S (2000) Ownership, competition, and the adoption of new technologies and cost-saving practices in a fixed-price environment. Inquiry 37:282–294

    Google Scholar 

  • Hoerger T (1991) ‘Profit’ variability in for-profit and not-for-profit hospitals. J Heal Econ 10:259–289

    Article  Google Scholar 

  • Horwitz J, Nichols A (2009) Hospital ownership and medical services: market mix, spillover effects and nonprofit objectives. J Heal Econ 28:924–937

    Article  Google Scholar 

  • Kane N, Manoukian P (1989) The effect of the Medicare prospective payment system on the adoption of new technology. N Engl J Med 321:1378–1383

    Article  Google Scholar 

  • Kesteloot K (1995) The economics of reimbursement and technological changes in cancer care. Eur J Cancer 31:1406–1409

    Article  Google Scholar 

  • Lakdawalla D, Philipson T (2006) The nonprofit sector and industry performance. J Public Econ 90:1681–1698

    Article  Google Scholar 

  • Ma C (1994) Health care payment systems: cost and quality incentives. J Econ Manag Strateg 3:93–112

    Article  Google Scholar 

  • Miraldo M (2007) Hospital financing and the development and adoption of new technologies, CHE Research Paper 26, Center for Health Economics, The University of York

  • Newhouse J (1970) Toward a theory of nonprofit institutions: an economic model of a hospital. Am Econ Rev 60:64–74

    Google Scholar 

  • RAND (2006) Effects of Medicare’s prospective payment system on the quality of hospital care. Research Highlights. http://www.rand.org/pubs/research_briefs/RB4519-1/index1.html. Last accessed May 16, 2012

  • Selder A (2005) Physician reimbursement and technology adoption. J Heal Econ 24:907–930

    Article  Google Scholar 

  • Siciliani L (2006) Selection of treatment under prospective payment systems in the hospital sector. J Heal Econ 25:479–499

    Article  Google Scholar 

  • Sloan F (2000) Not-for-profit hospital ownership and hospital behavior. Handbook Health Econ 1:1142–1161

    Google Scholar 

  • Sloan FH, Thoman J, Morrisey MA, Hassan M (1990) The demise of hospital philanthropy. Econ Inq 28:725–743

    Article  Google Scholar 

  • Teplensky JD, Pauly MV, Kimberly JR, Hillman AL, Schwartz JS (1995) Hospital adoption of medical technology: an empirical test of alternative models. Heal Serv Res 30:437–465

    Google Scholar 

  • Weisbrod B (1991) The health care quadrilemma: an essay on technological change, insurance, quality of care, and cost containment. J Econ Lit 29:523–552

    Google Scholar 

Download references

Acknowledgment

The comments of Seung Mo Choi, Dan Friesner, Bidisha Mandal and two anonymous referees are gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert E. Rosenman.

Appendix: Demand, waiting time and investment in quality

Appendix: Demand, waiting time and investment in quality

As discussed in the text and shown in Fig. 1, quality is a concave function of investment in quality. The minimum quality required for licensing is q min. Investment in quality increases the quality of output up to an investment level of t 1opt , after which further investment, because of crowding or other inefficiency, lowers quality – for investment beyond t 1opt the marginal product of the investment is negative. Hospitals will never invest more than t 1opt and the highest possible quality is q max so the range of quality for each hospital is \( \left[ {{q_{{\min }}},{q_{{\max }}}} \right] \). The difference in hospital quality is q f  − q n which has a range of \( \left[ {{q_{{\min }}} - {q_{{max}}},{q_{{\max }}} - {q_{{\min }}}} \right] \) where the lower end is realized if the for-profit hospital chooses t 1f  = 0 and the not-for-profit hospital chooses t 1n  = t 1opt and the upper end is realized if the choices are opposite. We note that if both hospitals choose the same level of quality investment, whatever level is chosen, then the hospital quality difference is 0.

Patients choose which hospital to go to by relative quality and waiting time. Waiting time, T k, at hospital k is a function of the number of patients choosing that hospital. For convenience, we assume waiting time is proportionate to the share of patients choosing each hospital. Individual consumers are attracted to a hospital if its differential quality is positive but repelled if its differential waiting time is positive. As is normal in congestion externalities, all patients ignore their own contribution to congestion, taking Q k , hence T k , as fixed, k = f, n.

Individual tolerances regarding waiting time are heterogeneous. The following characterization provides an example of how patients choose between relative quality and waiting time. Patient i chooses hospital y over hospital x if q y  − q x  > γ i where \( {\gamma_i} \in \left[ {0,{q_{{\max }}} - {q_{{\min }}} + \varepsilon } \right] \) measures her personal dislike for waiting time—it represents the heterogeneity of preferences about waiting time and relative quality—and ε is a small positive constant. Patients with γ i  = 0 have a high tolerance for waiting time and will always choose a hospital with higher quality. Those with γ i near its upper boundary have little tolerance for waiting time and, knowing a quality difference will attract patients to hospital y thus increasing the waiting time at that hospital, will go there only if the quality difference is very large. In fact, such is the disdain for waiting among some patients that they choose the lower quality hospital even if the quality difference is at its extreme value.

Given this behavior, the quality difference provides a metric of the share of patients using each hospital. At the lower end point where \( {q_f} - {q_n} = {q_{{\min }}} - {q_{{\max }}} \) almost all patients choose the not-for-profit hospital and only those patients with an extreme dislike of waiting (where γ i approaches its maximum value) use the for-profit hospital. At the other extreme where \( {q_f} - {q_n} = {q_{{\max }}} - {q_{{\min }}} \) most patients choose the for-profit hospital. Only those few patients who truly disdain waiting will go to the not-for-profit hospital—these are the same patients who would choose the for-profit hospital when it had the much lower quality.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, S., Rosenman, R.E. Reimbursement and Investment: Prospective Payment and For-Profit Hospitals’ Market Share. J Ind Compet Trade 13, 503–518 (2013). https://doi.org/10.1007/s10842-012-0147-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10842-012-0147-4

Keywords

JEL classification

Navigation